Zobrazeno 1 - 10
of 169
pro vyhledávání: '"K. Story"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sara K. Story, Sue Ann McCann
Publikováno v:
Journal of the Dermatology Nurses' Association. 5:305-313
Autor:
Larisa J. Geskin, Sara K. Story
Publikováno v:
Expert Review of Dermatology. 8:335-338
Over the last 15 years, the number of therapies for CTCL has grown rapidly and continues to do so as new medications are enter-ing clinical trials and seeking US FDA approval. Adverse events (AEs) related to a new therapy sometimes become the treatme
Publikováno v:
Leukemia & Lymphoma. 54:2448-2451
Balancing efficacy and safety of drugs is key for successful cancer therapy, as adverse reactions can prohibit the use of efficacious treatments. Pralatrexate (PDX) is a novel antifolate with a higher affinity for tumor cells than methotrexate, Food
Publikováno v:
The Oncologist. 18:301-307
Learning Objectives Describe the spectrum of diseases, represented by CD30+ lymphoproliferative disorders (LPDs), that can give rise to a reactive process. Discuss the favorable prognoses of reactive CD30+ LPDs and how they do not therefore require a
Publikováno v:
Journal of Clinical Oncology. 30:e283-e285
Cutaneous manifestations of internal malignancy encompass both direct extension of tumor to the skin and indirect involvement (the so-called paraneoplastic syndromes). Direct cutaneous manifestations parallel systemic disease in progression, remissio
Publikováno v:
Leukemialymphoma. 56(7)
Cutaneous T-cell lymphomas (CTCL) represent a group of non-Hodgkin's lymphomas comprised of skin-homing lymphocytes. Mycosis fungoides (MF), the most common form, is typically indolent, while Sezary syndrome (SS) is a less common, aggressive leukemic
Publikováno v:
Journal of drugs in dermatology : JDD. 13(6)
Monoclonal antibodies (mAb) have become the standard of care for numerous diseases. However, side effects including infusion and hypersensitivity reactions experienced by patients continue to be a limiting factor in their use. In the therapy of cance
Autor:
B. A. Benson, T. de Haan, J. P. Dudley, C. L. Reichardt, K. A. Aird, K. Andersson, R. Armstrong, M. L. N. Ashby, M. Bautz, M. Bayliss, G. Bazin, L. E. Bleem, M. Brodwin, J. E. Carlstrom, C. L. Chang, H. M. Cho, A. Clocchiatti, T. M. Crawford, A. T. Crites, S. Desai, M. A. Dobbs, R. J. Foley, W. R. Forman, E. M. George, M. D. Gladders, A. H. Gonzalez, N. W. Halverson, N. Harrington, F. W. High, G. P. Holder, W. L. Holzapfel, S. Hoover, J. D. Hrubes, C. Jones, M. Joy, R. Keisler, L. Knox, A. T. Lee, E. M. Leitch, J. Liu, M. Lueker, D. Luong-Van, A. Mantz, D. P. Marrone, M. McDonald, J. J. McMahon, J. Mehl, S. S. Meyer, L. Mocanu, J. J. Mohr, T. E. Montroy, S. S. Murray, T. Natoli, S. Padin, T. Plagge, C. Pryke, A. Rest, J. Ruel, J. E. Ruhl, B. R. Saliwanchik, A. Saro, J. T. Sayre, K. K. Schaffer, L. Shaw, E. Shirokoff, J. Song, H. G. Spieler, B. Stalder, Z. Staniszewski, A. A. Stark, K. Story, C. W. Stubbs, R. Suhada, A. van Engelen, K. Vanderlinde, J. D. Vieira, A. Vikhlinin, R. Williamson, O. Zahn, A. Zenteno
Publikováno v:
The Astrophysical Journal
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
We use measurements from the South Pole Telescope (SPT) Sunyaev-Zel'dovich (SZ) cluster survey in combination with X-ray measurements to constrain cosmological parameters. We present a statistical method that fits for the scaling relations of the SZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c8be450c4bca0b5ee5f192049e43c5
https://hdl.handle.net/11368/2963137
https://hdl.handle.net/11368/2963137